1. Home
  2. RFL vs VCIG Comparison

RFL vs VCIG Comparison

Compare RFL & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • VCIG
  • Stock Information
  • Founded
  • RFL 2017
  • VCIG 2013
  • Country
  • RFL United States
  • VCIG Malaysia
  • Employees
  • RFL N/A
  • VCIG N/A
  • Industry
  • RFL Real Estate
  • VCIG Diversified Commercial Services
  • Sector
  • RFL Finance
  • VCIG Consumer Discretionary
  • Exchange
  • RFL Nasdaq
  • VCIG Nasdaq
  • Market Cap
  • RFL 48.4M
  • VCIG 15.6M
  • IPO Year
  • RFL N/A
  • VCIG 2023
  • Fundamental
  • Price
  • RFL $1.73
  • VCIG $2.11
  • Analyst Decision
  • RFL
  • VCIG
  • Analyst Count
  • RFL 0
  • VCIG 0
  • Target Price
  • RFL N/A
  • VCIG N/A
  • AVG Volume (30 Days)
  • RFL 453.1K
  • VCIG 1.4M
  • Earning Date
  • RFL 06-11-2025
  • VCIG 08-18-2025
  • Dividend Yield
  • RFL N/A
  • VCIG N/A
  • EPS Growth
  • RFL N/A
  • VCIG N/A
  • EPS
  • RFL N/A
  • VCIG 54.73
  • Revenue
  • RFL $732,000.00
  • VCIG $27,819,290.00
  • Revenue This Year
  • RFL N/A
  • VCIG N/A
  • Revenue Next Year
  • RFL N/A
  • VCIG N/A
  • P/E Ratio
  • RFL N/A
  • VCIG $0.04
  • Revenue Growth
  • RFL 35.56
  • VCIG 36.99
  • 52 Week Low
  • RFL $1.27
  • VCIG $2.05
  • 52 Week High
  • RFL $3.19
  • VCIG $607.50
  • Technical
  • Relative Strength Index (RSI)
  • RFL 47.81
  • VCIG 35.13
  • Support Level
  • RFL $1.56
  • VCIG $3.04
  • Resistance Level
  • RFL $1.74
  • VCIG $3.03
  • Average True Range (ATR)
  • RFL 0.25
  • VCIG 0.30
  • MACD
  • RFL -0.04
  • VCIG 0.01
  • Stochastic Oscillator
  • RFL 13.48
  • VCIG 5.84

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.

Share on Social Networks: